COLRUYT SA (COLR.BR)

BE0974256852 - Common Stock

31.07  -0.01 (-0.03%)


Fundamental Rating

3

Taking everything into account, COLR scores 3 out of 10 in our fundamental rating. COLR was compared to 12 industry peers in the Consumer Staples Distribution & Retail industry. COLR has a medium financial health rating, its profitability is only medium as well. COLR has a expensive valuation and it also scores bad on growth




Profitability

Profitability Rating

4

COLR's Return On Assets of 3.56% is in line with the rest of the industry. The industry average Return On Assets is 3.56%.
COLR's Return On Equity of 8.94% is in line with the rest of the industry. The industry average Return On Equity is 12.10%.

COLR has a Profit Margin of 2.08%. This is comparable to the industry average of 2.08%.
The Piotroski-F score of COLR is 4.00. This is a neutral score and indicates average health and profitability for COLR.
VS Industry

ROA (3.56%) VS Industry: 57% outperformed.

1.38
6.35

ROE (8.94%) VS Industry: 42% outperformed.

7.82
16.39

Profit Margin (2.08%) VS Industry: 50% outperformed.

0.55
4.42

Valuation

Valuation Rating

0

With a Price/Earnings Ratio of 18.95, COLR is valued on the expensive side.
The Forward Price/Earnings Ratio of 18.62 indicates a rather expensive current valuation of COLR.
When comparing the current price to the book value of COLR, we can conclude it is valued correctly. It is trading at 1.65 times its book value.

Compared to an average industry Price/Earning Ratio of 15.24, COLR is valued slightly more expensive.
Compared to an average industry price book ratio of 1.59, COLR is valued more expensive than its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 5.83, COLR is valued more expensive than its industry peers.
VS Industry

Price/Earnings (18.95) VS Industry: 25% outperformed.

54.93
5.43

Price/Book (1.65) VS Industry: 33% outperformed.

5.33
0.23

Enterprise Value/ EBITDA (7.36) VS Industry: 37% outperformed.

11.48
3.55

Growth

Growth Rating

3

The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Earnings Per Share has been decreasing by -3.57% on average over the past 5 years.
Based on estimates for the next 5 years, COLR will show a decrease in Earnings Per Share. The EPS will decrease by -3.60% on average per year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.

COLR shows a small growth in Revenue. In the last year, the Revenue has grown by 4.16%.
The Revenue has been growing slightly by 1.14% on average over the past 5 years.
COLR is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 4.68% yearly.
The earnings per share for COLR have decreased strongly by -33.33% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-3.57% -8.07% -33.33% -32.94% -12.12% -4.79% -3.6%
Revenue1.14% 2.13% 4.16% 7.67% 5.69% 4.38% 4.68%

Health

Health Rating

4

The Debt to Equity ratio of COLR is way better than the industry averages. COLR has a better rating than 100% of its industry peers.
An Altman-Z score of 2.87 indicates that COLR is not a great score, but indicates only limited risk for bankruptcy at the moment.
COLR has a Altman-Z score comparable to the industry average, which is at 2.74.
The Piotroski-F score of COLR is 4.00. This is a neutral score and indicates average health and profitability for COLR.

COLR has a Current Ratio of 0.72. This is a bad value and indicates that COLR is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Current Ratio of COLR to the average industry Current Ratio of 0.80, COLR is less able to pay its short term obligations than its industry peers. 80% of its industry peers have a better Current Ratio.
A Quick Ratio of 0.42 indicates that COLR may have some problems paying its short term obligations.
When comparing the Quick Ratio of COLR to the average industry Current Ratio of 0.49, COLR is less able to pay its short term obligations than its industry peers. 90% of its industry peers have a better Quick Ratio.
VS Industry

Debt/Equity (0.26) VS Industry: 100% outperformed.

4.18
0.26

Quick Ratio (0.42) VS Industry: 10% outperformed.

0.40
2.28

Current Ratio (0.72) VS Industry: 20% outperformed.

0.71
2.89

Altman-Z (2.87) VS Industry: 60% outperformed.

0.95
5.03

Dividend

Dividend Rating

3

COLR has a Yearly Dividend Yield of 2.49%.
Compared to an average S&P500 Dividend Yield of 2.72, COLR has a dividend comparable with the average S&P500 company.
The dividend of COLR has a limited annual growth rate of 5.05%.

With a Dividend Yield of 2.49, COLR pays less dividend than the industry average, which is at 3.46. 84% of the companies listed in the same industry pay a better dividend than COLR!
The Dividend Rate of COLR has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (2.49%) VS Industry: 16% outperformed.

2.46
5.71

COLRUYT SA

EBR:COLR (5/30/2023, 2:51:11 PM)

31.07

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.96B
Analysts45.88
Price Target24.45 (-21.31%)
Dividend
Industry RankSector Rank
Dividend Yield 2.49%
Dividend Growth(5Y)5.05%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)-9.8%
Min EPS beat(2)-9.8%
Max EPS beat(2)-9.8%
EPS beat(4)N/A
Avg EPS beat(4)-9.47%
Min EPS beat(4)-9.8%
Max EPS beat(4)-9.13%
Revenue beat(2)N/A
Avg Revenue beat(2)-2.15%
Min Revenue beat(2)-2.15%
Max Revenue beat(2)-2.15%
Revenue beat(4)N/A
Avg Revenue beat(4)-1.83%
Min Revenue beat(4)-2.15%
Max Revenue beat(4)-1.52%
PT rev (1m)4.35%
PT rev (3m)7.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-15.4%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.5%
Valuation
Industry RankSector Rank
PE 18.95
Fwd PE 18.62
P/S 0.38
P/FCF N/A
P/OCF 9.69
P/B 1.65
P/tB 2.09
EV/EBITDA 7.36
EPS(TTM)1.64
EY5.28%
EPS(NY)1.67
Fwd EY5.37%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)3.21
OCFY10.32%
SpS81.12
BVpS18.87
TBVpS14.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.56%
ROE 8.94%
ROIC 7.19%
ROICexc 8.27%
ROICexgc 10.15%
OM 2.84%
PM 2.08%
GM 27.12%
ROICexgc(3y)15.38%
ROICexcg growth 3Y-15.1%
ROICexcg growth 5Y-12.56%
ROICexc(3y)13.28%
ROICexc growth 3Y-17.31%
ROICexc growth 5Y-14.27%
OM growth 3Y-10.53%
OM growth 5Y-6.45%
PM growth 3Y-10.99%
PM growth 5Y-6.6%
GM growth 3Y1.49%
GM growth 5Y1.49%
F-Score4
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 2.1
Cap/Depr 127.18%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.42
Altman-Z 2.87
F-Score4
WACC6.52%
ROIC/WACC1.56
Cap/Depr(3y)138.07%
Cap/Depr(5y)142.47%
Profit Quality(3y)54.9%
Profit Quality(5y)48.38%
Growth
EPS 1Y-33.33%
EPS 3Y-8.07%
EPS 5Y-3.57%
EPS growth Q2Q-42.98%
EPS Next Y-32.94%
EPS Next 2Y-12.12%
EPS Next 3Y-4.79%
EPS Next 5Y-3.6%
Revenue growth 1Y4.16%
Revenue growth 3Y2.13%
Revenue growth 5Y1.14%
Revenue growth Q2Q5.73%
Revenue Next Year7.67%
Revenue Next 2Y5.69%
Revenue Next 3Y4.38%
Revenue Next 5Y4.68%
EBIT growth 1Y-30.92%
EBIT growth 3Y-8.63%
EBIT growth 5Y-5.38%
EBIT Next Year55.99%
EBIT Next 3Y21.06%
EBIT Next 5Y16.68%
FCF growth 1Y-119.33%
FCF growth 3Y-57.58%
FCF growth 5Y-38.36%
OCF growth 1Y-47.44%
OCF growth 3Y-4.08%
OCF growth 5Y-1.47%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext